Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study.

Background: The WHO emphasized the importance of knowing the risk factors for the severity of the disease in the COVID-19 pandemic. Our aim in this study was to determine the relationship between serum Butyrylcholinesterase (BChE) level, which is rapidly affected by inflammation, and the severity of COVID-19 pneumonia and mortality.

Methods: Patients diagnosed with COVID-19 pneumonia between March and May 2021 were included in the study.